Page 4 - புற்றுநோயியல் பார்மா இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புற்றுநோயியல் பார்மா இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புற்றுநோயியல் பார்மா இன்க் Today - Breaking & Trending Today

Oncology Pharma Inc.: Oncology Pharma, Inc. Prepares Plan Toward Funding Development and Implementation of Ribera Solutions' Patient Engagement and Retention Platform

(0)
SAN FRANCISCO, CA / ACCESSWIRE / April 21, 2021 /
Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the Company ) is moving ahead with advancing its efforts with Ribera Solutions Conect2Med platform with Oncology Pharma s exclusivity for oncology, including drug development, clinical trials, personalized oncology and therapeutics. Ribera has been developing its platform and Oncology Pharma, under its License Agreement, is preparing the necessary steps to proceed to advance the development and implementation.
Connect2Med is a patient engagement and retention platform designed to improve the clinical trial experience for both patients and providers. With Connect2Med, sponsors, CROs, and sites have a place for leads, or people in their databases, to live in an online community. The platform provides a private, secure space where people interested in or recruited to clinical trials have a safe, closed community they can join that provides trustworthy info ....

United States , San Francisco , Kostenloser Wertpapierhandel , Ribera Solutions , Oncology Pharma Inc , Oncology Pharma , Ribera Solution Conect , License Agreement , Advisory Board , Sansome Street , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , ரிபேரா தீர்வுகள் , புற்றுநோயியல் பார்மா இன்க் , புற்றுநோயியல் பார்மா ,

Oncology Pharma, Inc. Prepares Plan Toward Funding Development and Implementation of Ribera Solutions' Patient Engagement and Retention Platform

Oncology Pharma, Inc. Prepares Plan Toward Funding Development and Implementation of Ribera Solutions' Patient Engagement and Retention Platform
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Ribera Solutions , Oncology Pharma Inc , Oncology Pharma , Ribera Solution Conect , License Agreement , Advisory Board , Sansome Street , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , ரிபேரா தீர்வுகள் , புற்றுநோயியல் பார்மா இன்க் , புற்றுநோயியல் பார்மா ,

Oncology Pharma, Inc. Addresses Pancreatic Cancer, the Need for an Effective Therapy and the Potential of mRNA Technology

Oncology Pharma, Inc. Addresses Pancreatic Cancer, the Need for an Effective Therapy and the Potential of mRNA Technology
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Regen Biopharma Inc , Oncology Pharma Inc , National Cancer Institute , A Spokesperson For The Company , Oncology Pharma , Regen Biopharma , Pancreatic Cancer , Advisory Board , Sansome Street , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , புற்றுநோயியல் பார்மா இன்க் , தேசிய புற்றுநோய் நிறுவனம் , புற்றுநோயியல் பார்மா , கணையம் புற்றுநோய் ,

Oncology Pharma Inc.: Oncology Pharma Signs License Agreement for mRNA Intellectual Property As It Reveals Strategic Plans for Treating Pancreatic Cancer

(1)
SAN FRANCISCO, CA / ACCESSWIRE / April 7, 2021 /
Oncology Pharma Inc. (OTC PINK:ONPH) signed a license agreement with Regen BioPharma Inc. for intellectual property pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer. This license agreement expands the Company s portfolio of intellectual property that It plans to develop for niche biotechnology markets.
Oncology Pharma issued a statement We are looking to expand our presence in the cancer therapy market. This showcases our commitment to developing quality therapies to make patients lives better.
A spokesperson for the Company said the company believes this is a major milestone for the company and is evidence of it achieving its goals in brand development. ....

San Francisco , United States , Kostenloser Wertpapierhandel , Regen Biopharma Inc , Oncology Pharma Inc , Oncology Pharma , Regen Biopharma , Advisory Board , Sansome Street , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , புற்றுநோயியல் பார்மா இன்க் , புற்றுநோயியல் பார்மா ,

Oncology Pharma Signs License Agreement for mRNA Intellectual Property As It Reveals Strategic Plans for Treating Pancreatic Cancer

Oncology Pharma Signs License Agreement for mRNA Intellectual Property As It Reveals Strategic Plans for Treating Pancreatic Cancer
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

San Francisco , United States , Regen Biopharma Inc , Oncology Pharma Inc , Oncology Pharma , Regen Biopharma , Advisory Board , Sansome Street , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , புற்றுநோயியல் பார்மா இன்க் , புற்றுநோயியல் பார்மா ,